The literature showed that rs11571316 may increase the susceptibility of cervical cancer by increasing the expression level of the CTLA4 (40); we indicated that rs11571316 involved in RA pathogenesis and inflammatory response may result from upregulating the CTLA4 expression. The gene discussed is CTLA4; the disease is cervical carcinoma.